vs
Avantor, Inc.（AVTR）与ROKU, INC（ROKU）财务数据对比。点击上方公司名可切换其他公司
Avantor, Inc.的季度营收约是ROKU, INC的1.2倍（$1.7B vs $1.4B），ROKU, INC净利率更高（5.8% vs 3.1%，领先2.6%），ROKU, INC同比增速更快（16.1% vs -1.4%），Avantor, Inc.自由现金流更多（$117.2M vs $106.6M），过去两年ROKU, INC的营收复合增速更高（25.8% vs -0.5%）
Avantor是一家总部位于美国宾夕法尼亚州拉德诺的生物技术、化工及制药领域企业，前身为1904年成立的J.T. Baker，2010年正式更名，2019年在纽约证券交易所挂牌上市，股票代码为AVTR，为全球生命科学、医疗健康等行业客户提供核心产品与服务。
Roku是美国流媒体技术企业，2002年由安东尼·伍德创立，主营数字媒体播放器、电视硬件生产，流媒体内容分发及平台广告运营。截至2024年覆盖用户达1.45亿，是美国流媒体视频分发领域的市场领导者，业务覆盖澳、加、法、德、英及拉美多国。
AVTR vs ROKU — 直观对比
营收规模更大
AVTR
是对方的1.2倍
$1.4B
营收增速更快
ROKU
高出17.5%
-1.4%
净利率更高
ROKU
高出2.6%
3.1%
自由现金流更多
AVTR
多$10.6M
$106.6M
两年增速更快
ROKU
近两年复合增速
-0.5%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $1.7B | $1.4B |
| 净利润 | $52.4M | $80.5M |
| 毛利率 | 31.5% | 43.5% |
| 营业利润率 | 7.6% | 4.7% |
| 净利率 | 3.1% | 5.8% |
| 营收同比 | -1.4% | 16.1% |
| 净利润同比 | -89.5% | 326.4% |
| 每股收益（稀释后） | $0.08 | $0.55 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AVTRROKU
| Q4 25 | $1.7B | $1.4B | ||
| Q3 25 | $1.6B | $1.2B | ||
| Q2 25 | $1.7B | $1.1B | ||
| Q1 25 | $1.6B | $1.0B | ||
| Q4 24 | $1.7B | $1.2B | ||
| Q3 24 | $1.7B | $1.1B | ||
| Q2 24 | $1.7B | $968.2M | ||
| Q1 24 | $1.7B | $881.5M |
净利润AVTRROKU
| Q4 25 | $52.4M | $80.5M | ||
| Q3 25 | $-711.8M | $24.8M | ||
| Q2 25 | $64.7M | $10.5M | ||
| Q1 25 | $64.5M | $-27.4M | ||
| Q4 24 | $500.4M | $-35.5M | ||
| Q3 24 | $57.8M | $-9.0M | ||
| Q2 24 | $92.9M | $-34.0M | ||
| Q1 24 | $60.4M | $-50.9M |
毛利率AVTRROKU
| Q4 25 | 31.5% | 43.5% | ||
| Q3 25 | 32.4% | 43.4% | ||
| Q2 25 | 32.9% | 44.8% | ||
| Q1 25 | 33.8% | 43.6% | ||
| Q4 24 | 33.4% | 42.7% | ||
| Q3 24 | 32.9% | 45.2% | ||
| Q2 24 | 34.1% | 43.9% | ||
| Q1 24 | 34.0% | 44.1% |
营业利润率AVTRROKU
| Q4 25 | 7.6% | 4.7% | ||
| Q3 25 | -40.0% | 0.8% | ||
| Q2 25 | 7.7% | -2.1% | ||
| Q1 25 | 9.3% | -5.7% | ||
| Q4 24 | 37.8% | -3.3% | ||
| Q3 24 | 7.3% | -3.4% | ||
| Q2 24 | 10.3% | -7.4% | ||
| Q1 24 | 8.7% | -8.2% |
净利率AVTRROKU
| Q4 25 | 3.1% | 5.8% | ||
| Q3 25 | -43.8% | 2.0% | ||
| Q2 25 | 3.8% | 0.9% | ||
| Q1 25 | 4.1% | -2.7% | ||
| Q4 24 | 29.7% | -3.0% | ||
| Q3 24 | 3.4% | -0.9% | ||
| Q2 24 | 5.5% | -3.5% | ||
| Q1 24 | 3.6% | -5.8% |
每股收益（稀释后）AVTRROKU
| Q4 25 | $0.08 | $0.55 | ||
| Q3 25 | $-1.04 | $0.16 | ||
| Q2 25 | $0.09 | $0.07 | ||
| Q1 25 | $0.09 | $-0.19 | ||
| Q4 24 | $0.73 | $-0.24 | ||
| Q3 24 | $0.08 | $-0.06 | ||
| Q2 24 | $0.14 | $-0.24 | ||
| Q1 24 | $0.09 | $-0.35 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $365.4M | $2.3B |
| 总债务越低越好 | $3.9B | — |
| 股东权益账面价值 | $5.6B | $2.7B |
| 总资产 | $11.8B | $4.4B |
| 负债/权益比越低杠杆越低 | 0.71× | — |
8季度趋势，按日历期对齐
现金及短期投资AVTRROKU
| Q4 25 | $365.4M | $2.3B | ||
| Q3 25 | $251.9M | $2.3B | ||
| Q2 25 | $449.4M | $2.3B | ||
| Q1 25 | $315.7M | $2.3B | ||
| Q4 24 | $261.9M | $2.2B | ||
| Q3 24 | $285.3M | $2.1B | ||
| Q2 24 | $272.6M | $2.1B | ||
| Q1 24 | $234.9M | $2.1B |
总债务AVTRROKU
| Q4 25 | $3.9B | — | ||
| Q3 25 | $3.9B | — | ||
| Q2 25 | $4.2B | — | ||
| Q1 25 | $4.1B | — | ||
| Q4 24 | $4.1B | — | ||
| Q3 24 | $4.9B | — | ||
| Q2 24 | $5.1B | — | ||
| Q1 24 | $5.3B | — |
股东权益AVTRROKU
| Q4 25 | $5.6B | $2.7B | ||
| Q3 25 | $5.6B | $2.6B | ||
| Q2 25 | $6.3B | $2.6B | ||
| Q1 25 | $6.1B | $2.5B | ||
| Q4 24 | $6.0B | $2.5B | ||
| Q3 24 | $5.6B | $2.5B | ||
| Q2 24 | $5.4B | $2.4B | ||
| Q1 24 | $5.3B | $2.4B |
总资产AVTRROKU
| Q4 25 | $11.8B | $4.4B | ||
| Q3 25 | $11.7B | $4.4B | ||
| Q2 25 | $12.8B | $4.3B | ||
| Q1 25 | $12.3B | $4.2B | ||
| Q4 24 | $12.1B | $4.3B | ||
| Q3 24 | $12.8B | $4.3B | ||
| Q2 24 | $12.7B | $4.1B | ||
| Q1 24 | $12.8B | $4.2B |
负债/权益比AVTRROKU
| Q4 25 | 0.71× | — | ||
| Q3 25 | 0.69× | — | ||
| Q2 25 | 0.67× | — | ||
| Q1 25 | 0.67× | — | ||
| Q4 24 | 0.68× | — | ||
| Q3 24 | 0.89× | — | ||
| Q2 24 | 0.94× | — | ||
| Q1 24 | 1.00× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $152.7M | $107.7M |
| 自由现金流经营现金流 - 资本支出 | $117.2M | $106.6M |
| 自由现金流率自由现金流/营收 | 7.0% | 7.6% |
| 资本支出强度资本支出/营收 | 2.1% | 0.1% |
| 现金转化率经营现金流/净利润 | 2.91× | 1.34× |
| 过去12个月自由现金流最近4个季度 | $495.0M | $478.4M |
8季度趋势，按日历期对齐
经营现金流AVTRROKU
| Q4 25 | $152.7M | $107.7M | ||
| Q3 25 | $207.4M | $127.6M | ||
| Q2 25 | $154.4M | $109.7M | ||
| Q1 25 | $109.3M | $138.7M | ||
| Q4 24 | $173.3M | $79.3M | ||
| Q3 24 | $244.8M | $68.7M | ||
| Q2 24 | $281.1M | $23.4M | ||
| Q1 24 | $141.6M | $46.7M |
自由现金流AVTRROKU
| Q4 25 | $117.2M | $106.6M | ||
| Q3 25 | $171.7M | $126.5M | ||
| Q2 25 | $124.8M | $108.6M | ||
| Q1 25 | $81.3M | $136.8M | ||
| Q4 24 | $145.8M | $76.8M | ||
| Q3 24 | $204.0M | $67.6M | ||
| Q2 24 | $235.3M | $22.5M | ||
| Q1 24 | $106.9M | $46.0M |
自由现金流率AVTRROKU
| Q4 25 | 7.0% | 7.6% | ||
| Q3 25 | 10.6% | 10.4% | ||
| Q2 25 | 7.4% | 9.8% | ||
| Q1 25 | 5.1% | 13.4% | ||
| Q4 24 | 8.6% | 6.4% | ||
| Q3 24 | 11.9% | 6.4% | ||
| Q2 24 | 13.8% | 2.3% | ||
| Q1 24 | 6.4% | 5.2% |
资本支出强度AVTRROKU
| Q4 25 | 2.1% | 0.1% | ||
| Q3 25 | 2.2% | 0.1% | ||
| Q2 25 | 1.8% | 0.1% | ||
| Q1 25 | 1.8% | 0.2% | ||
| Q4 24 | 1.6% | 0.2% | ||
| Q3 24 | 2.4% | 0.1% | ||
| Q2 24 | 2.7% | 0.1% | ||
| Q1 24 | 2.1% | 0.1% |
现金转化率AVTRROKU
| Q4 25 | 2.91× | 1.34× | ||
| Q3 25 | — | 5.14× | ||
| Q2 25 | 2.39× | 10.45× | ||
| Q1 25 | 1.69× | — | ||
| Q4 24 | 0.35× | — | ||
| Q3 24 | 4.24× | — | ||
| Q2 24 | 3.03× | — | ||
| Q1 24 | 2.34× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AVTR
| Laboratory Solutions Segment | $1.1B | 67% |
| Bioscience Production Segment | $547.5M | 33% |
ROKU
| Services | $1.2B | 88% |
| Products | $170.9M | 12% |
